EBV EARLY ANTIGEN (R+D)

EBV EARLY ANTIGEN (R+D) is an FDA 510(k)-cleared medical device (K884829) manufactured by Hillcrest Biologicals. This device is classified under the Microbiology specialty. FDA Device Class I (General Controls) — lowest risk category. FDA clearance granted on April 11, 1989. Regulation: 8.